Regulatory approvals from Health Canada received to formulate and distribute cannabinoid-free nutraceutical products
YEDI Venture Fund’s undisclosed investment in Folium Labs Inc., a Canadian-based biotechnology and consumer products company, has advanced provision of nutraceuticals across North America.
“We are excited that YEDI Venture Fund sees potential in Folium Labs,” says Dmitri Boudovitch, CEO of Folium Labs. “This is a huge step for us to accelerate our go-to-market strategy delivering Livli nutraceuticals to consumers across North America and beyond,” Boudovitch says.
“Folium Labs has received all regulatory approvals from Health Canada to formulate and distribute cannabinoid-free nutraceutical products to help combat potential drawbacks of short-term and long-term cannabis use while helping consumers to improve overall cannabis experience,” notes a statement from the company.
In early February, Folium Labs launched the first Livli product, a daily non-GMO multi-vitamin for cannabis users. “The company has plans to unleash more health products in the near future,” the statement adds.
Want to keep up to date on what’s happening in the world of cannabis? Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.
Full story is available here.